The Little Clinic provided more than 111,000 free health screenings in 2009
BRENTWOOD, Tenn. The Little Clinic, which currently operates retail-based clinics in 11 states, provided more than $1 million worth of free health screenings in 2009 as part of its effort to provide preventative medical services for consumers during the economic downturn.
According to the Brentwood, Tenn.-based clinic operator, it provided more than 111,000 free health screenings valued at $1.3 million throughout 2009. Men, women, children and seniors took advantage of the program at The Little Clinic locations in select Kroger and Publix Super Markets.
“We understand the importance of health monitoring because serious problems often arise when issues such as high blood pressure and high cholesterol are not addressed immediately. Based on the volume of free screenings given, it is clear that our program offered a much needed health service to the communities where we operate and underscores the valuable role that retail clinics have in increasing access to care, particularly for preventative healthcare services,” stated Lisa Loscalzo, president of The Little Clinic. “An added side benefit was serving many consumers who may not have had these health screenings performed due to the effects of the challenging economy.”
Each month, The Little Clinic offered screenings such as blood pressure, cholesterol, blood sugar, child growth percentiles and others. In addition, The Little Clinic provided information and related screenings on a monthly health focus, including skin cancer, diabetes, breast cancer awareness and cold/flu. Clinic providers administered the screenings, answered questions, provided consultation to the patient and also shared information related to specific health topics such as ways to lower body mass index, maintaining lung health and healthy snacks for adults and children.
New report projects sales of Parkinson’s disease drug will reach $500 million
WALTHAM, Mass. A drug made by Boehringer Ingelheim for treating Parkinson’s disease could have sales of up to half a billion dollars, according to a new analysis.
According to a report released Tuesday by market research firm Decision Resources, BI’s extended-release formulation of pramipexole will have peak-year sales of between $250 million and $500 million in major pharmaceutical markets. The drug was launched in Europe in 2009 and is expected to enter the market in the United States this year.
In the beginning, according to the report, launches of generic formulations of the immediate-release version of pramipexole and competition from GlaxoSmithKline’s and SkyePharma’s Requip XL (ropinirole CR) and generic versions of immediate-release Requip will put a damper on sales of pramipexole ER. However, physician familiarity with the drug and preference among physicians and patients for once-daily dosing will cause a “significant” increase in sales.
“Given physician comfort in prescribing pramipexole for Parkinson’s disease and the convenience of once-daily dosing that it would offer, we expect that pramipexole ER will take much of pramipexole IR’s patient share,” Decision Resources analyst Sami Fam said. “In the short term, we expect pramipexole ER will lose some patient share to ropinirole CR given that ropinirole CR was the first of the two agents to launch. But over the long term, physicians’ slight preference for pramipexole over ropinirole should help to boost pramipexole ER’s uptake.”
Report: Weis Markets acquires local Medicine Shoppe pharmacy
SUNBURY, Pa. Weis recently acquired a Medicine Shoppe pharmacy in the Binghamton, N.Y., market, local newscaster News Channel 34 (owned by Newport Television) reported early Tuesday morning.
Weis Markets currently has 120 in-store pharmacies at other locations and is considering more at its Broome County locations, the report noted.